Format

Send to

Choose Destination
J Med Ethics. 1998 Dec;24(6):401-8.

Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.

Author information

1
Veterans Affairs Medical Center, San Francisco, USA.

Abstract

Randomised clinical trials provide the most valid means of establishing the efficacy of clinical therapeutics. Ethical standards dictate that patients and clinicians should not consent to randomisation unless there is uncertainty about whether any of the treatment options is superior to the others ("equipoise"). However, true equipoise is rarely present; most randomised trials, therefore, present challenging ethical dilemmas. Minimising the tension between science and ethics is an obligation of investigators and clinicians. This article briefly reviews several techniques for addressing this issue and suggests that unbalanced randomisation, a technique rarely employed in current clinical trial practice, may be useful for enhancing the ethical design of human experimentation.

PMID:
9873981
PMCID:
PMC479141
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center